AFREZZA MONOPACK
Live / Applied — Second extension granted (statement of use) (as of 26 Jan 2026)
What this means for you
Not registered yet, but its 19 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98657517
- Mark type
- Stylized text
- Filed
- 19 Jul 2024
- Published for opposition
- 10 Dec 2024
- Attorney of record
- Jaclyne D. Wallace
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders; pharmaceutical preparations containing insulin for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders; inhaler systems, comprised of inhalers and cartridges, both filled with pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders
Owner
- MannKind Corporation, Danbury, CT, US
- MannKind Corporation, Danbury, CT, US
Prior registrations
Prosecution history
- 27 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jan 2026 — SOU EXTENSION 2 GRANTED
- 26 Jan 2026 — SOU EXTENSION 2 FILED
- 26 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Sept 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 07 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 May 2025 — SOU EXTENSION 1 GRANTED
- 06 May 2025 — SOU EXTENSION 1 FILED
- 06 May 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Dec 2024 — PUBLISHED FOR OPPOSITION
- 04 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED